Home > Insider Trading > Filing (0001209191-23-003702)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1426332	Ngm Biopharmaceuticals Inc	NGM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1642996	Jin-Long Chen	C/O Ngm Biopharmaceuticals, Inc. 333 Oyster Point Boulevard South San Francisco CA 94080	Chief Scientific Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-17	85,082	$1.44	993,975	No	4	M	Direct
Common Stock	Disposition	2023-01-17	85,082	$5.15	908,893	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-01-17	85,082	$0.00	85,082	$1.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2023-01-23	No	4	M	Direct

Footnotes

The exercise occurred because the option was expiring, and shares were sold to pay the exercise price and related tax obligations.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $5.015 to $5.30. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Fully vested.